Account Info
Log Out
English
Back
Download
Log in to access Online Inquiry
Back to the Top
avatar
70794700 commented on a stock · Aug 10, 2023 12:25

$Roivant Sciences (ROIV.US)$ shall easily beat the 2023 Q2 e...

$Roivant Sciences(ROIV.US)$ shall easily beat the 2023 Q2 estimate as its VTAMA Leads the Other Branded Topicals in Weekly TRx in Q2 already (see below). More important, investors may be more interested in its business update about potential deals from the next Monday earnings meeting.
$Roivant Sciences (ROIV.US)$ shall easily beat the 2023 Q2 estimate as its VTAMA Leads the Other Branded Topicals in Weekly TRx in Q2 already (see below). More ...
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
+0
Translate
Report
7905 Views
Comment
Sign in to post a comment
    avatar
    70794700
    2Followers
    1Following
    19Visitors
    Follow